Skip to main content

Life Technologies Will Collaborate with German Cancer Research Center on New Sequencing Center


This story was originally published June 2

Life Technologies announced last week that it will collaborate with the German Cancer Research Center to create a new sequencing center.

The National High-Throughput Sequencing Center will be the largest sequencing center in Germany and will be partially funded by the German Federal Ministry of Education and Research.

The center will be equipped with 10 SOLiD 4 systems, and its initial projects will include the sequencing of 1,000 whole human cancer genomes as Germany's contribution to the International Cancer Genome Consortium.

The center will carry out experiments involving not only whole-genome sequencing, but also transcriptome sequencing and copy number analyses, in order to get a comprehensive picture of the genetic nature of disease.

Life Technologies' president and COO Mark Stevenson said in a statement that the center "will be the first facility that will systematically bring high-throughput sequencing technology into systems biology applications on a large scale."

Roland Eils, head of the theoretical bioinformatics division at the German Cancer Research Center, said in a statement that the center's goal is to "understand the dynamic complexity of cellular processes on both the DNA and RNA level and how slight perturbations of those pathways contribute to the development of diseases like cancer,"

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.